Queen Palm, IgE, Serum
Use
The test is useful for establishing a diagnosis of an allergy to queen palm by identifying the specific allergens responsible for triggering allergic responses or anaphylactic episodes. It confirms sensitization prior to starting immunotherapy and investigates the specificity of allergic reactions to insect venom allergens, drugs, or chemical allergens. Additionally, the presence of IgE antibodies in serum is indicative of an increased likelihood of allergic disease and helps define allergens that may be responsible for causing clinical symptoms.
Special Instructions
Not provided.
Limitations
Some individuals may possess detectable levels of IgE antibodies without significant clinical sensitivity to allergens, leading to potential false-positive results. Additionally, patients with markedly elevated serum IgE (>2500 kU/L) might also display false-positive results due to nonspecific binding to allergen solid phases. These factors necessitate interpreting test results within a clinical context.
FDA ApprovedNew York Approved
Methodology
Immunoassay (FEIA)
Biomarkers
LOINC Codes
- 6222-4 - Queen Palm IgE Qn
- 6222-4 - Queen Palm IgE Qn
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL for every 5 allergens requested
Minimum Volume
For 1 allergen: 0.3 mL; For more than 1 allergen: (0.05 mL x number of allergens) + 0.25 mL deadspace
Container
Preferred: Serum gel; Acceptable: Red top; Submission Container: Plastic vial
Collection Instructions
Centrifuge and aliquot serum into a plastic vial.
Causes for Rejection
Gross hemolysis: OK, Gross lipemia: OK
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 14 days |
| Frozen | 90 days |